PURPOSE: The 21-gene recurrence score (RS) assay is used to guide breast cancer treatment decisions but can be poorly understood by patients. We examined the effects of a question prompt list (QPL) on knowledge, distress, and decisional conflict related to genomic testing and treatment in early-stage breast cancer. METHODS: We describe the feasibility and acceptability of the QPL and the impact of the QPL on knowledge, distress, and decisional conflict before and after the receipt of the QPL (MEND 2, N = 65). We also compared distress and decisional conflict between women who received the QPL (MEND 2, N = 65) and a comparable group of women who did not receive the QPL who participated in an earlier observational study within the same clinics (MEND 1, N = 136). RESULTS: MEND 2 participants indicated high acceptability and feasibility using the QPL. Knowledge increased post-QPL (P < .01) but did not decrease distress. Decisional conflict was lower among women in MEND 2 compared with those in MEND 1 (P < .01), with no statistically significant differences in distress. CONCLUSION: The findings suggest that the QPL is feasible, acceptable, can improve knowledge and decrease decisional conflict in the large group of women deciding treatment while integrating RS test results.
PURPOSE: The 21-gene recurrence score (RS) assay is used to guide breast cancer treatment decisions but can be poorly understood by patients. We examined the effects of a question prompt list (QPL) on knowledge, distress, and decisional conflict related to genomic testing and treatment in early-stage breast cancer. METHODS: We describe the feasibility and acceptability of the QPL and the impact of the QPL on knowledge, distress, and decisional conflict before and after the receipt of the QPL (MEND 2, N = 65). We also compared distress and decisional conflict between women who received the QPL (MEND 2, N = 65) and a comparable group of women who did not receive the QPL who participated in an earlier observational study within the same clinics (MEND 1, N = 136). RESULTS: MEND 2 participants indicated high acceptability and feasibility using the QPL. Knowledge increased post-QPL (P < .01) but did not decrease distress. Decisional conflict was lower among women in MEND 2 compared with those in MEND 1 (P < .01), with no statistically significant differences in distress. CONCLUSION: The findings suggest that the QPL is feasible, acceptable, can improve knowledge and decrease decisional conflict in the large group of women deciding treatment while integrating RS test results.
Authors: Joseph A Sparano; Robert J Gray; Peter M Ravdin; Della F Makower; Kathleen I Pritchard; Kathy S Albain; Daniel F Hayes; Charles E Geyer; Elizabeth C Dees; Matthew P Goetz; John A Olson; Tracy Lively; Sunil S Badve; Thomas J Saphner; Lynne I Wagner; Timothy J Whelan; Matthew J Ellis; Soonmyung Paik; William C Wood; Maccon M Keane; Henry L Gomez Moreno; Pavan S Reddy; Timothy F Goggins; Ingrid A Mayer; Adam M Brufsky; Deborah L Toppmeyer; Virginia G Kaklamani; Jeffrey L Berenberg; Jeffrey Abrams; George W Sledge Journal: N Engl J Med Date: 2019-06-03 Impact factor: 91.245
Authors: Susan Eggly; Lauren M Hamel; Tanina S Foster; Terrance L Albrecht; Robert Chapman; Felicity W K Harper; Hayley Thompson; Jennifer J Griggs; Richard Gonzalez; Lisa Berry-Bobovski; Rifky Tkatch; Michael Simon; Anthony Shields; Shirish Gadgeel; Randa Loutfi; Haythem Ali; Ira Wollner; Louis A Penner Journal: Patient Educ Couns Date: 2016-12-27
Authors: Mark N Levine; Jim A Julian; Philippe L Bedard; Andrea Eisen; Maureen E Trudeau; Brian Higgins; Louise Bordeleau; Kathleen I Pritchard Journal: J Clin Oncol Date: 2015-11-23 Impact factor: 44.544
Authors: Michael J Hassett; Samuel M Silver; Melissa E Hughes; Douglas W Blayney; Stephen B Edge; James G Herman; Clifford A Hudis; P Kelly Marcom; Jane E Pettinga; David Share; Richard Theriault; Yu-Ning Wong; Jonathan L Vandergrift; Joyce C Niland; Jane C Weeks Journal: J Clin Oncol Date: 2012-05-14 Impact factor: 44.544
Authors: Nadiyah Sulayman; Elizabeth Spellman; Kristi D Graves; Beth N Peshkin; Claudine Isaacs; Marc D Schwartz; Suzanne C O'Neill Journal: J Cancer Epidemiol Date: 2012-07-30
Authors: Suzanne C O'Neill; Susan T Vadaparampil; Richard L Street; Tanina Foster Moore; Claudine Isaacs; Hyo S Han; Bianca Augusto; Jennifer Garcia; Katherine Lopez; Matilda Brilleman; Jinani Jayasekera; Susan Eggly Journal: Patient Educ Couns Date: 2020-09-03
Authors: Jessica Gacki-Smith; Brianna R Kuramitsu; Max Downey; Karen B Vanterpool; Michelle J Nordstrom; Michelle Luken; Tiffany Riggleman; Withney Altema; Shannon Fichter; Carisa M Cooney; Greg A Dumanian; Sally E Jensen; Gerald Brandacher; Scott Tintle; Macey Levan; Elisa J Gordon Journal: Front Psychol Date: 2022-09-05
Authors: Andreas Schönau; Sara Goering; Erika Versalovic; Natalia Montes; Tim Brown; Ishan Dasgupta; Eran Klein Journal: Front Hum Neurosci Date: 2022-07-29 Impact factor: 3.473